Opportunity to provide digital data and decentralized trial services for multi-institutional cancer trials led by NCI-supported organizations WILMINGTON, N.C. -- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of [...]

Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfully completed extended concordance testing on Olink’s platforms (Olink® Target 48/96 and Olink® Explore), fulfilling specific requirements that supplement the Olink quality acceptance criteria. This latest validation was initiated by and implemented in cooperation with a leading global [...]

ZEISS Lattice Lightsheet 7 enables the gentle 3D imaging of living cells Jena / Munich, Germany -- Today, the Office of the Federal President announced the nominations for the German Future Prize (Deutscher Zukunftspreis) at the German Museum in Munich. ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen and Ralf Wolleschensky have been nominated for [...]

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN’s NGS testing portfolio for precision medicine beyond oncology into neurology applications HILDEN, Germany & GERMANTOWN Md. & SOUTH SAN FRANCISCO, Calif. -- QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc., an early stage [...]

Paris - GTT announces it has taken a minority stake in the Norwegian technology start-up Tunable AS, via a €6.4 million investment round co-led with TRUMPF Venture, with the participation of the company's existing shareholders. Tunable AS designs and manufactures compact multi-gas analysers based on MEMS[1] technology, combining micro and nanotechnology with infrared spectroscopy[2]. The sensors developed [...]

Cory Stevenson, former President of the BioProduction division at Thermo Fisher Scientific joins Board FORT LAUDERDALE, Fla and SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Cory Stevenson to its Board of Directors. [...]

Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it has invested in six genomics startups for the fifth global funding cycle of [...]

Doubling the company’s footprint in Silicon Valley, a hot spot for the promising Biologics and Advanced Therapeutics area, is a testament to Biotage’s commitment and priority to continuously invest and strengthen its presence as a supplier to the Pharma and BioPharma drug discovery and development industry. In April 2022, Biotage established a new site for [...]

INDIANAPOLIS and DUBLIN, IRELAND – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of [...]

Highly customizable synthetic guide RNA (gRNA) libraries, coupled with established CRISPR expertise and support, enables researchers to quickly screen for new drug candidates CORALVILLE, Iowa — Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider Integrated DNA Technologies (IDT) is expanding access to its customization [...]